Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Braeburn Pharmaceuticals
>
Sales Expansion
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="anonymous, post: 5981059"]Judging by the comments on their board, one would think it's the worst company out there. But go to any pharma company board and you'll see the exact same bitching. I didn't jump for this company bc they have a shitty track record in the short time they've been around, and they're nowhere near as financially solvent as Indivior is. Have they EVER turned a profit? Indivior already has the jump on them, with a product that appears clinically superior, at least on paper. CAM's doses are low for the monthly, and a weekly injectable seems like more trouble than it's worth for offices. Some went for the payday, and I have a feeling they'll regret it. Indivior, for all its faults, still has over a decade of experience in this market and did their homework with their new injectable. As AP stated, Indivior isn't big pharma in terms of overhead and staff so they can absorb some revenue loss without slashing sales force. And they're in a much better financial position than Braeburn. This isn't an Indivior homer talking, but someone who is looking at both companies as objectively as possible. And you can't discount the brand recognition either, naming their product something similar to Suboxone will help. Managed care will determine a lot, but again I don't trust a start up over a company with years of relationships in this area.[/QUOTE]</p><p><br /></p>
[QUOTE="anonymous, post: 5981059"]Judging by the comments on their board, one would think it's the worst company out there. But go to any pharma company board and you'll see the exact same bitching. I didn't jump for this company bc they have a shitty track record in the short time they've been around, and they're nowhere near as financially solvent as Indivior is. Have they EVER turned a profit? Indivior already has the jump on them, with a product that appears clinically superior, at least on paper. CAM's doses are low for the monthly, and a weekly injectable seems like more trouble than it's worth for offices. Some went for the payday, and I have a feeling they'll regret it. Indivior, for all its faults, still has over a decade of experience in this market and did their homework with their new injectable. As AP stated, Indivior isn't big pharma in terms of overhead and staff so they can absorb some revenue loss without slashing sales force. And they're in a much better financial position than Braeburn. This isn't an Indivior homer talking, but someone who is looking at both companies as objectively as possible. And you can't discount the brand recognition either, naming their product something similar to Suboxone will help. Managed care will determine a lot, but again I don't trust a start up over a company with years of relationships in this area.[/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Braeburn Pharmaceuticals
>
Sales Expansion
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Braeburn Pharmaceuticals
>
Sales Expansion
>